Toxicity of chemical substances to male reproductive system has been focused since the effects of a pesticide, dibromochloropropane (DBCP), on human spermatogenesis were discovered (Whorton et al., 1977) . Because the damages on reproductive system may cause infertility and endanger the survival of the species, it is necessary to establish a simple way to evaluate the mechanism of reproductive toxicity of chemical substances for controlling and preventing their adverse effects. Testicular toxicity, a major male reproductive toxicity (Nishikawa et al., 2010) ABSTRACT -Testicular toxicity of chemical substances has been generally assessed by sperm properties and histology. However, the methods can provide only a few information of the mechanism of the toxicity. The aim of this study is to show a method that can evaluate an overview of testicular toxic mechanisms using a tissue-specific microarray and classification of genes using Medical Subject Headings (MeSH). Male ICR mice (6 weeks old) were treated with doxorubicin hydrochloride (0, 0.1, 0.3 mg/kg/ time, three times per week) by subcutaneous injection for 6 weeks (until 11 weeks old). Six weeks after the final administration, tissue and blood samples were obtained. Testes were subjected to gene expression analysis using quantitative RT-PCR and cDNA microarray (testis2). To interpret the microarray data, genes were classified using MeSH related to the functions of testis and sperm. Doxorubicin (both 0.1 and 0.3 mg/kg group) induced a decrease in sperm normal morphology and mortality, daily sperm production, and the number of Sertoli cells in the seminiferous tubules. Quantitative RT-PCR and microarray analysis showed dysregulation of mRNA expression levels of genes related to Sertoli cells, germ cells and spermatogenesis. Analysis of microarray data showed a significant enrichment of a total of ten MeSH categories including Spermatogenesis, Sertoli cells, Germ cells and Male infertility. This article concluded that analysis using testicular specific microarray combined with MeSH showed a more comprehensive overview of testicular toxic mechanisms than existing methods; i.e., examination of sperm properties and the histological examinations.
INTRODUCTION
ty, sperm morphology and sperm count and by the histological examination of Leydig cells, Sertoli cells and spermatogenic cells (Oshio et al., 1987; Matsui and Takahashi, 1999; Kato et al., 2001) . The assays are useful for determine if the substances influence detrimental effects on male reproductive system; however, by only using these examinations, it is difficult to understand the precise mechanism of testicular toxicity. Although there are several reports of microarray analysis of testicular toxicity, discussion of the mechanisms eliciting the toxicity has been limited. Recently, we developed a method of microarray analysis combined with Medical Subject Headings (MeSH) for interpretation of microarray results in physiopathological and toxicological research , Shimizu et al., 2009 . It has been supposed that MeSH is useful for interpretation of microarray data from the biological viewpoint (Masys et al., 2001; Nakazato et al., 2007; Umezawa et al., 2009) . We attempted to establish a method that can evaluate the overview of testicular toxic mechanisms using a tissue-specific microarray, Mouse Testis2. The effects of doxorubicin, a typical chemotherapeutic drug for cancer known to be toxic for testicular functions damage (Meistrich et al., 1982; Oshio et al., 1987) , were analyzed on testis tissue using microarray technology. The results were compared with previous reports on the mechanisms of testicular toxicity of doxorubicin.
MATERIALS AND METHODS

Doxorubicin hydrochloride (Adriacin)
Doxorubicin hydrochloride (Adriacin) was purchased from Kyowa Hakko Kogyo Co., Ltd. (Tokyo, Japan). It was dissolved in saline (Otsuka Pharmaceutical Co., Ltd., Tokyo, Japan) at concentrations of 20 and 60 μg/ml for administration.
Animals and Treatments
Male ICR mice (6-week-old) were purchased from Japan SLC Inc. (Shizuoka, Japan) and housed in a room under controlled temperature (23 ± 1°C), humidity (55 ± 5%) and light (12 hr light/12 hr dark cycle with light on at 8:00 a.m.) with ad libitum access to chow and water. All animals were handled in accordance with institutional and national guidelines for the care and use of laboratory animals.
Doxorubicin hydrochloride (0, 0.1, 0.3 mg/kg/time, three times per week) was administered subcutaneously to male ICR mice for 6 weeks (6-11 weeks of age). Mice in the control group received only saline on the same schedule as the treated groups. After a washout period of 46 days, the mice were weighed and sacrificed under hyperanesthesia using diethyl ether, as a simple anesthetic compound used in a previous study (Oshio et al., 1987) , to obtain tissues of testis, epididymis, accessory reproductive organs (prostate, seminal vesicles and coagulating glands) and blood samples. The doses and study protocol followed the previous study to examine testicular toxicity by Oshio et al. (1987) .
Organ weight and treatment of testis tissue
The weight of testis, epididymis and accessory reproductive organs was bilaterally measured for each animal. After weighing, a piece of the right testis was fixed with Bouin's fluid and embedded in paraffin for histological observation as described later. The remainder of the right testis was immediately frozen in liquid nitrogen and stored at -80°C until use for RNA extraction. The left testis was frozen at -80°C until thawing for sperm counts.
Sperm morphology and motility
Sperm suspension was collected from the cauda epididymis by mincing in HEPES-buffered TYH medium (pH 7.4) and prepared for examination of sperm motility and morphology as previously described (Oshio et al., 1987 (Oshio et al., , 1990 . To quantitate the sperm motility, sample aliquots of 20 μl were placed on a hemocytometer and more than 200 sperms were observed and counted under a phase contrast microscope (BX51, Olympus Co., Tokyo, Japan) and a video system. The samples were kept at 37°C using a counting chamber Standard Count 2 Chamber Slide 20 micron (Leja, Nieuw Vennep, Netherland) and a constanttemperature unit MP-10 (Kitazato Supply Co. Ltd., Shizuoka, Japan). Percentage motile sperm was defined as Nm/Ns×100 (%), where Nm is the number of forward motile and submotile sperm and Ns is the number of sperm in the view area.
Daily sperm production
Testicular tissue was thawed at room temperature and weighed after removal of any extra capsular materials from the testis. They were homogenized for 2 min in 1 ml of saline containing 0.05% Triton X-100 (Nacalai Tesque, Inc., Kyoto, Japan) and 0.2% Eosin Y (Merck & Co, Inc., Whitehouse station, NJ, USA). The concentration of sperm nuclei in each suspension was determined using a hemocytometer and relative numbers (concentration of sperm nuclei/weight of testis) were calculated as previously described (Ono et al., 2007 (Ono et al., , 2008 .
Testicular morphology and counting Sertoli cells
Bouin's fixed testis was embedded in paraffin and cut Vol. 36 No. 5 into 6-μm sections. Sections were stained with hematoxylin and eosin (HE) and observed by light microscopy. A total of five seminiferous tubules exhibiting a round shape were randomly selected in samples of each mouse, and the number of Sertoli cells was counted.
ELISA
The serum testosterone concentration was measured by an enzyme-linked immunosorbent assay (testosterone ELISA kit, Alpha Diagnotic Intl, Inc., San Anterio, TX, USA).
Total RNA extraction
Testis tissue for gene expression analysis was homogenized in Isogen (Nippon Gene Co., Ltd., Tokyo, Japan). Total RNA was isolated according to the manufacturer's protocol and suspended in RNase-free water. The RNA quantity was determined by spectrophotometry at OD260 in a Smart Spec 3000 (Bio-Rad Laboratories Inc., Tokyo, Japan). 2 mg of RNA from each sample was provided for quantitative RT-PCR and the rest was used for microarray analysis.
Quantitative RT-PCR
RNAs (2 μg) were treated with DNase (Promega Co., Madison, WI, USA) and then reverse-transcribed into cDNA using M-MLV reverse transcriptase (Invitrogen Co., Carlsbad, CA, USA) according to the manufacturer's instructions. Quantitative PCR was performed with specific oligo-primer pairs (Nippon EGT, Toyama, Japan) and SYBR Green Realtime PCR Master Mix (Toyobo Co. Ltd., Osaka, Japan) using a PRISM 7700 Sequence Detection System (Perkin-Elmer Applied Biosystems, Carlsbad, CA, USA). The primer sequences are shown in Table S1 (Supplementary Material).
Statistical analysis
The Steel Dwass test was performed to compare the data of three groups. A P value of less than 0.05 was considered to be significant.
Complementary DNA microarray
RNAs for microarray analysis were pooled equally from each sample to 45 μg for each group, purified using the RNeasy Micro Kit (Qiagen, Hilden, Germany) and reverse-transcribed to yield complementary DNA (cDNA) labeled with the fluorescent dye Cy3 or Cy5 using the SuperScript Indirect cDNA Labeling Core Kit (Invitrogen) and the SuperScript Indirect cDNA Labeling System Purification Kit (Invitrogen). Cy3-and Cy5-labeled samples were purified using the CyScribe GFX Purification Kit (GE Healthcare Bio-Sciences, Little Chalfont, UK). The generated targets were mixed and subjected to hybridization to a Mouse Testis2 Array (AGC Techno Glass Co. Ltd., Chiba, Japan) consisting of 2482 gene probes. Microarrays were scanned with two different photomultiplier sensitivities using a ScanArray (Packard BioChip Technologies, Erie, PA, USA). The scanner output images were normalized by locally weighted scatter plot smoothing (LOWESS) and signal quantitation was performed using ScanArray Express (Perkin Elmer, MA, USA) and SilicoCyte (CytoGenomics, St. Louis, MO, USA). Normalization was performed so that the overall intensity ratio of Cy3 and Cy5 was equal to one. Statistical analysis was performed with analysis of variance. The expression threshold levels were more than 1.5-fold and less than 0.67-fold with a P value of less than 0.05.
Functional analysis of microarray data using Medical Subject Headings
Thirty MeSH terms related to testicular function and male hormone were chosen (Table 1 ). All genes printed on the microarray were annotated with the selected terms using the gene reference database PubGene (https://server.pubgene.com/online/PubGene/, Pub Gene AS, Oslo, Norway). The genes for which dysregulation were detected were categorized with the MeSH terms. The enrichment factor for each category was defined as (nf/n)/ (Nf/N), where nf is the number of differentially expressed genes within the category, n is the total number of genes within that same category, Nf is the number of differentially expressed genes on the microarray, and N is the total number of genes on the microarray. Statistical analysis was performed using Fisher's exact test with hypergeometric distribution.
RESULTS
Weight of body and reproductive organs
To determine the general toxicity of doxorubicin, body and reproductive organ weights were measured. The high-dose treated group (0.3 mg/kg x 18) had significantly lighter testis and epididymis weights (Table 2) .
Sperm count, morphology and motility
Sperm count indicating the level of sperm production, and epididymal sperm morphology and motility were significantly lower in mice treated with doxorubicin than in control mice. These effects were dependent on the dose of doxorubicin (Fig. 1) .
Testicular morphology
Doxorubicin induced a shedding of immature germ cells and a disruption of Sertoli cell structure in the seminiferous tubules (Figs 2B and C) . It showed that doxorubicin prevents sperm differentiation. The number of Sertoli cells was also decreased in the treated groups (Fig. 3) .
Serum testosterone concentration
The medians of testosterone concentration in serum were 0.96 ng/ml, 3.64 ng/ml and 9.70 ng/ml in the control group, the low-dose treated group and the high-dose treated group, respectively (Fig. 4) . No significant change was found among the groups.
Quantitative RT-PCR
Expression levels of Csk, Cdk5, Axl, Prep and Cav1 were examined by quantitative RT-PCR. In the high-dose treated group, testicular mRNA expression of Csk, Cdk5
and Prep was significantly higher than in the control group. An increase in expression of these genes was dosedependent. mRNA expression of Axl and Cav1 was also significantly higher in the high-dose treated group than in the control group. The expression of Axl was also significantly increased in the low-dose treated group compared to the control group (Fig. 5) .
cDNA microarray
From the 2,482 genes printed on the Mouse Testis2 Arrays, 99 and 313 genes were found to be upregulated in testis of the low-dose and the high-dose treated groups compared to the control group, respectively. 188 and 304 genes were found to be downregulated in the low-dose and the high-dose treated groups, respectively (Table 3) . Functional analysis of the data with gene annotation showed that the 8 and 5 MeSH categories were enriched significantly by the low-dose and the high-dose treat- 289.9 ± 9.6 281.8 ± 8.1 194.9 ± 11.7*** Epididymis (mg) 107.7 ± 2.8 105.8 ± 2.7 86.8 ± 3.1** Accessory gland (mg) 295.4 ± 18.2 351.6 ± 26.4 312.3 ± 18.3 Data are presented as mean ± S.E.M. ***P < 0.001, **P < 0.01 vs control. Vol. 36 No. 5 ed groups, respectively (Table 4) . For genes with a foldchange of > 1.5 or < 0.67 and P < 0.05 in either the lowor high-dose treated groups, the largest and dominant categories within the enriched MeSH was Spermatogenesis (8 genes) together with Germ Cells (6 genes). Dosedependent data of doxorubicin-induced expression change of the genes were shown in Fig. 6 .
DISCUSSION
In the present study, the effect of doxorubicin on testicular gene expression was examined by a tissue-specific microarray. The doses of doxorubicin and the test schedule were determined by a previous study of their damaging effects on mouse spermatozoa (Oshio et al., 1987) . Previous studies have shown that a decrease in sperm motility was induced by administration of 0.3 mg/kg of doxorubicin hydrochloride, three times a week for 6 weeks (Oshio et al., 1987 (Oshio et al., , 1989 but not by 0.1 mg/ kg of doxorubicin hydrochloride. The weight of reproductive organ was not affected in the low-dose treated group but was significantly lighter in the high-dose treated group. Our data also showed that sperm production, morphology and motility were decreased dosedependently in the doxorubicin-treated groups. This observation was consistent with previous studies using mice (Oshio et al., 1987) and rats (Imahie et al., 1995; Prahalathan et al., 2005) . A shedding of immature germ cells, indicating the disruption of sperm differentiation, and a decrease in the number of Sertoli cells were also observed in the treated groups. A similar observation was found in rats that received a high dose of a single intraperitoneal injection of doxorubicin (3 mg/kg) within 48 hr (Hou et al., 2005) . It has been reported that doxorubicin suppresses the function of Sertoli cells in vitro and in vivo followed by impairment of spermatogenesis . The number of Sertoli cells is generally correlated with the level of spermatogenesis (Sharpe et al., 2003) . It was also shown that doxorubicin induces degeneration and apoptosis of germ cells in meiotically dividing spermatocytes (Shinoda et al., 1999; Kato et al., 2001) , which were responsible for the adverse effect on male infertility. Our data showed that the serum testosterone level was not significantly affected by doxorubicin (0.3 mg/kg x 18 times in 6 weeks). In a previous study, the serum testosterone level was decreased by a high-dose of doxorubicin (10 mg/kg) (Ateşşahin et al., 2006) ; this difference appears to be caused by the difference of the dose of doxorubicin. This data suggests that the doses in this study are useful for investigating the mechanisms of testicular toxicity without affecting testosterone levels in the blood.
Quantitative RT-PCR analysis showed that dysregulation of Csk, Cdk5, Axl, Prep and Cav1, the genes associated with spermatogenesis and the functions of Sertoli cells and germ cells. Csk is expressed on Sertoli cells (Wine and Chapin, 1999; Lee and Cheng, 2005) and participates in the remodeling of seminiferous tubules during spermatogenesis (Gye et al., 2004) . Cdk5 is also expressed on meiotic metaphase spermatogonia, Leydig cells, semiferous epithelium and especially on the nuclei and the cytoplasm of Sertoli cells (Musa et al., 1998; Session et al., 2001) . Axl is a tyrosine kinase expressed on Sertoli cells and plays an important role in the differentiation of germ cells (Lu et al., 1999; Wang et al., 2005) . Upregulation of such genes is considered to be associated with maintaining homeostasis of the environment in the seminiferous tubules under conditions where the number of Sertoli cells decreases. Prep is an endopeptidase which is reported to be associated with necrozoospermia. Its activity is mainly in the soluble sperm fraction and is higher in necrozoospermic semen (Valdivia et al., 2004) . Cav1 is present on membrane rafts of developing germ cells (Travis et al., 2001) and plays a role in cholesterol trafficking (Casanova et al., 2006; Travis et al., 2001) . Upregulation of Prep and Cav1 corresponds to the observation of a decrease in sperm motility in the doxorubicintreated groups. The causal connection between the dysregulation of the genes and the alterations of testis and sperm was not determined; however, expression levels of the genes may be significant markers of testicular toxicity. The results showed that dose dependent treatment with doxorubicin induced changes in gene expression related to regulation of Sertoli cell function and sperm motility. Vol. 36 No. 5 Functional analysis of the microarray data showed a total of 10 enriched MeSH categories as an effect of doxorubicin on testicular gene expression. Among the enriched MeSH terms, "Sertoli cells", "Androgens" and "Androgen Receptors" in the low-dose treated group, "Spermatogenesis" in the high-dose treated group and "Germ cells" in both of the treated groups were of interest with respect to the mechanisms eliciting testicular toxicity. The result of the Sertoli cell count showed a significant difference in the number of Sertoli cells per seminiferous tubule between the doxorubicin-treated groups and the control group, but the count was similar between the low-dose and high-dose treated groups. This was consistent with the result of the MeSH analysis of microarray data, which showed that Sertoli cells were enriched according to the data of the low-dose treated group vs the control group but not according to the data of the highdose treated group vs the control group. Especially, foldincrease of expression of Pla2g4a, one of the genes in the phospholipase (PL) A2 group, was higher in the low-dose treated group compared to the high-dose treated group. PLA2 is related to Sertoli cell function (Meroni et al., 2003) and matured sperm motility (Bao et al., 2004) . Of interest is that cytosolic PLA2 is associated with apoptosis in CD95-expressing cells (Ulisse et al., 2000) , which may include spermatocytes (Lizama et al., 2007) . Degeneration and apoptosis of germ cells are well known as observations of toxicity of doxorubicin (Shinoda et al., 1999; Kato et al., 2001) . The reverse correlation of Pla2g4a expression may be associated with doxorubicininduced death of germ cells in the low-dose treated group and the extent of doxorubicin-suppressed sperm motility. The high-dose doxorubicin induced expression change in a greater number of genes related to "Infertile, Male" and "Spermatogenesis". This showed that doxorubicin affects spermatogenesis dose-dependently and may induce male infertility. "Androgens" and "Androgen Receptors" were also enriched, although the serum testosterone level was not affected by doxorubicin in the present study (0.1 and 0.3 mg/kg x 18 in 6 weeks). This suggested that low-dose doxorubicin may induce expression change of genes related to androgens and their receptors, even if the dose did not reach a level affecting the serum concentration of testosterone. It should be noted that the results showed that exposure to different doses of doxorubicin leads to enrichment of different MeSH categories. This fact may reflect different mechanisms of toxicity triggered by different concentrations of the substance, which is a common situation in toxicology. The result of microarray showed an apparent discrepancy in fold-change of Suv39h1, encoding a histone methyltransferase, between the low-and high-dose treated groups. Association of epigenetics and chromosomal stability related to Suv39h1 (Peters et al., 2001 ) with doxorubicin-induced toxicity on testis is of interest, but further investigations are needed to determine their mechanistic link in the doxorubicin-treated condition.
In conclusions, our data suggested that doxorubicin reduced the number of Sertoli cells followed by a decrease in production, normal morphology and motility of sperm in a dose-dependent manner. Analysis of microarray data showed that enriched MeSH categories corresponded to those observed in previous reports and provided additional data related to changes in gene expression, which may be linked to the mechanism underlying testicular toxicity. This report showed that the method is useful for determining overview of the mechanisms of testicular toxicity caused by chemical and environmental substances.
